is tirzepatide still on the fda shortage list Eli Lilly's off FDA's drug list: Here's what it means Eli Lilly's Weight-Loss Drug Zepbound

This study further strengthens the case for using GLP-1 agonists in obese patients with HFpEF, a type of heart failure that is associated with significant morbidity and mortality, said Pooja Prasad, MD, an assistant clinical professor in the Department of Advanced Heart Failure & Transplant Cardiology at the University of California San Francisco

Most importantly, remember that weight loss is not just about looking better but also about feeling healthier.

healthcare system is at a turning point as the dual epidemics of obesity and type 2 diabetes drive demand for advanced treatments

This medication is similar to a gut hormone known as GLP-1, which helps patients feel fuller faster and suppresses appetite

In rare situations, when individuals cant join a clinical trial and have run out of treatment options, Lilly may provide an investigational medicine in coordination with a requesting physician, a Lilly spokesperson told The Independent in a statement